Welcome to our online store!

More Views

Vezomni 30 tablets 6 mg solifenacin succinate / 0.4 mg tamsulosin hydrochloride Cancer Везомни

Product sku: MD3324

Availability: In stock

Only 10 left


Quick Overview

Benign prostatic hyperplasia


Vezomni Indications

Treatment of symptoms of bladder filling (imperative urges to urinate, more frequent urination) from moderate to severe and bladder emptying symptoms (obstructive symptoms) associated with benign prostatic hyperplasia (BPH) in men with ineffective monotherapy.


Hypersensitivity to active substances or to any of the excipients. Hemodialysis. Heavy liver failure. Severe renal failure, in which potent inhibitors of cytochrome P450 (CYP) 3A4, such as ketoconazole, are used. Moderate hepatic impairment, in which strong CYP3A4 inhibitors, such as ketoconazole, are also used.

Severe gastro-intestinal diseases (including toxic megacolon), myasthenia gravis or closed-angle glaucoma and the risk of developing these diseases. Presence of anamnesis of orthostatic hypotension.

Dosage & Administration

1 tablet (6 mg / 0.4 mg) once daily regardless of meals.

Maximum daily dose is 1 tablet (6 mg / 0.4 mg).

Tabkets should be taken whole, not chewed or crushed.

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.